pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
ELREXFIO
ELREXFIO (ELRANATAMAB)
1 INDICATIONS AND USAGE ELREXFIO is indicated for the tre…
$PFE
PFIZER INC
ELTROMBOPAG
ELTROMBOPAG
no indication
ZYDUS PHARMS
Phase 2
ELU-42
Diabetic Foot Ulcers
Eluciderm Inc
ELURYNG
ELURYNG (ETONOGESTREL AND ETHINYL ESTRADIOL)
no indication
← prev
page 90 of 271
next →
Pain
89
Neurology
1
AMNEAL
Phase 1
ELVN-001
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$ELVN
Enliven Therapeutics, Inc.
Phase 2
ELVN-002
Human Epidermal Growth Factor Receptor 2 Positive Breast…
$ELVN
Enliven Therapeutics, Inc.
Preclinical
EMD-101
Neutropenia
EmendoBio Inc
Preclinical
EMD-202
Retinitis Pigmentosa (Retinitis)
EmendoBio Inc
Preclinical
EMDRX-9
cannabidiol
Pain
Emyria Ltd
EMROSI
EMROSI (MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE)
no indication
JOURNEY
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE (EMTRICITABINE)
no indication
Macleods Pharmaceuticals Ltd
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
no indication
CHARTWELL RX
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE)
no indication
Apotex Corp
Phase 2
EN-374
Chronic Granulomatous Disease
Ensoma Inc
ENALAPRIL MALEATE ORAL SOLUTION
ENALAPRIL MALEATE ORAL SOLUTION
no indication
ALKEM LABS LTD
Phase 2
ENB-003
Pancreatic Cancer
ENB Therapeutics LLC
Phase 3
ENB-106
Diabetic Retinopathy
Ennovabio
Phase 3
ENERGIF-703
Diabetic Foot Ulcers
Energenesis Biomedical Co Ltd
ENHERTU
ENHERTU (FAM-TRASTUZUMAB DERUXTECAN-NXKI)
no indication
Daiichi Sankyo Co Ltd
ENOXAPARIN SODIUM (PRESERVATIVE FREE)
ENOXAPARIN SODIUM (PRESERVATIVE FREE) (ENOXAPARIN SODIUM)
no indication
Shenzhen Techdow Pharmaceutical Co Ltd
Phase 1
ENS-002
Atopic Dermatitis (Atopic Eczema)
Concerto Biosciences Inc
ENSACOVE
ENSACOVE (ENSARTINIB HYDROCHLORIDE)
no indication
Xcovery Holdings Inc
Phase 1
ENV-308
Obesity
Enveda Biosciences Inc
Phase 1
ENV-6946
Inflammatory Bowel Disease
Enveda Biosciences Inc
ENZEEVU
ENZEEVU (AFLIBERCEPT-ABZV)
no indication
Sandoz Inc
Phase 1
EO-2002
Corneal Edema
Emmecell LLC
Phase 2
EO-2463
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…
Enterome Bioscience SA
EOVIST
EOVIST (GADOXETATE DISODIUM)
no indication
BAYER HLTHCARE
Preclinical
EP-055
Male Contraception
Eppin Pharma Inc
Phase 2
EPI-321
Facioscapulohumeral Muscular Dystrophy (FSHD)
Epicrispr Biotechnologies Inc
